Animal model of autism

[1][2][3][4]The development of an animal model of autism is one approach researchers use to study potential causes of autism.[5] Given the complexity of autism and its etiology, researchers often focus only on single features of autism when using animal models.[6]

Rodent model

One of the more common rodent models is the Norway rat (Rattus norvegicus).[7] More recent research has used the house mouse (Mus musculus) to model autism because it is a social species. Other strains of mice used include mu opioid receptor knockout mice, as well as Fmr1 knockout mice; the latter are also used as animal models of Fragile X syndrome.[8]

The Norway rat has been used, for example, by Mady Hornig to implicate thiomersal in autism.[9][10] The current scientific consensus is that no convincing scientific evidence supports these claims,[11][12] and major scientific and medical bodies such as the Institute of Medicine[11] and World Health Organization[13] (WHO) as well as governmental agencies such as the U.S. Food and Drug Administration[14] (FDA) and Centers for Disease Control and Prevention[15] (CDC) reject any role for thiomersal in autism or other neurodevelopmental disorders.

Behaviors measured in these models include "approach to olfactory pheromones emitted by other mice, approach to familiar and new conspecifics, reciprocal social interactions, ultrasonic vocalizations, communal nesting, sexual and parenting behaviors, territorial scent marking, and aggressive behaviors."[16] Social interaction is measured by how the mouse interacts with a stranger mouse introduced in the opposite side of a test box.[17]

Researchers from the University of Florida have used deer mice to study restricted and repetitive behavior such as compulsive grooming, and how these behaviors may be caused by specific gene mutations.[18] In addition, Craig Powell of the University of Texas Southwestern Medical Center, with a grant from Autism Speaks,[19] is currently using mice to examine the potential role of neuroligin gene mutations in causing autism. Much research has been done into the use of a rat model to show how Borna virus infection,[20][21] exposure to valproic acid in utero,[22] and maternal immune activation[23] may cause autism.

Another goal of the use of rodent models to study autism is to identify the mechanism by which autism develops in humans.[5] Other researchers have developed an autism severity score to measure the degree of severity of the mice's autism, as well as the use of scent marking behavior[24] and vocalization distress[17] as models for communication.

It has been observed that mice lacking the gene for oxytocin exhibit deficits in social interaction, and that it may be possible to develop treatments for autism based on abnormalities in this and other neuropeptides.[25][26]


Environmental Factors of ASD

  Looking at the environmental factors of autistic spectrum disorder in rodents helps us to understand the neuropathology of the disorder which can be compared to humans. Environmental factors have been studied in animal rodent models and have been seen to influence brain development and play a role in CNS neuropathology. For example, one study found that a possible environmental contributor to autism may be agents like prenatal exposure to air pollution or any birth difficulty leading to periods of oxygen deprivation to the brain, which alter serotonin levels in early development of the rodent1. This study also found that if the parent exhibits autism, the offspring are more likely to be infected as well and that since older men have a higher number of DNA mutations in their sperm, these mutations are usually found in the offspring of older men. The last major result that this study observed was that environmental factors during and after pregnancy may have an impact on the immune system as well as the developing nervous system and plays a part in creating neurodevelopmental disorders like autism1. Since environmental factors can occur at any time during the developmental process, there is lots of variability in the neural and behavioral phenotype of autism. The environment can cause unknown changes in brain development of rodents because they don’t all live in the same habitat and therefore might develop different changes to their brain than what is expected.

Genetic and Phenotypic Factors of ASD

  There have been six autism-related genes that are linked to the X chromosome when it comes to autistic spectrum disorder1. The first gene that has been linked to autism is the Fragile X mental retardation gene (Fmr1). For example, rodents with this gene exhibit elevated cortical spine densities that are similar to those found in autism as well as decreased social behaviors. Another gene that has been linked to autism is methyl-CpG- binding protein type 2 gene (MECP2). In the rodent models that have MECP2 disruption, the rodents are usually normal up until the sixteenth week of age and then they start to develop extreme anxiety in the field, reduced nest building, and poor social interactions which are all symptoms of autism1. The third and fourth genes that have been linked to autism are neuroligin (NLGN) 3 and 4 genes. One study found that mutations in the NLGN 3 and 4 genes lead to loss of neuroligin processing to stimulate the formation of synapses which is a feature of autistic spectrum disorders2. The fifth and sixth genes that are linked to autism are the tuberous sclerosis genes (TSC1 and TSC2). Mutations in one of these two genes cause multiple benign tumors to grow in multiple tissues like the brain2. Lastly, many of the abnormalities found in autistic spectrum disorders involve the mTOR signaling pathway, the GABA - containing neurons, and the immune system.

Human Autism Spectrum Disorder

  Understanding human neurodevelopmental disorders often requires adequate models to understand the overall nature of the disorder and the general impacts the disorder makes on the brain itself. Naturally each disorder has different implications when it comes to genetic makeup, phenotypically and genotypically, and generally this impacts particular brain regions. In Autism Spectrum Disorder (ASD) it is generally seen in reduced developmental growth within the brain, and more specifically reduced gray matter within the medial temporal lobe (MTL), which is where the amygdala and hippocampus are located. This is critical in understanding Autism because this region of the brain controls emotions and learning, which is symptomatically linked to ASD. In addition, this supports the need for animal models that establish a greater understanding of what effects these particular brain regions and genetics have on development, and if there are measures we can take to prevent the onset of the disorder3.

Neuropathology of the Underdeveloped Synapse

  Autism Spectrum Disorder (ASD) is caused by developmental delays that cause the brain to have lower connectivity within particularly important regions. The synapses within the brain have critical importance in development in young children, especially during their critical period. Autistic brains often have delayed or early critical periods, causing complications within the brain’s developmental stages and ability to create stronger synapses for basic communication and stimulus recognition4. Furthermore, the brain’s lessened development and cognitive delays are usually observable within the genetics and grey matter within the brain3. 
  Rodent models have been established as good examples because their brains are akin to humans in makeup. Additionally, they have similar social interactions and relationships that humans have, which shows the social development symptoms often used to diagnose ASD. Rodents when used as models are compared to their normal developed brains, but to replicate ASD, the rodents are lesioned prior to birth using prenatal valproate (VPA). The rodents then experience similar symptoms and developmental changes that occur with human’s with ASD. Human’s with ASD are identified to have a single-gene mutation at Neuroligin-3, or NL-3 R451C. These particularly simple changes to the rodents and human brains impact them greatly in their ability to develop properly4.

Neuropathology of GABA Receptors

  Rodents, most especially mice, are excellent animal models of autism because they have similar social relationships and neuroscience. When exposed to prenatal valproate (VPA) during pregnancy, the mice are born with basic deformities and the developmental delays seen symptomatically in humans5. This is all comparable and easier to study since the lifespan of mice and most rodents is shorter, so being able to understand the genetics, minute effects, and test methods to reduce the onset of the disorder allows for researchers to develop new treatment methods quickly and effectively to help humans on the spectrum. Additionally, these rodents may trace back particular models to how the developmental delays occur in relation to GABA5. GABA is a neurotransmitter that is generally seen as inhibitory, but prior to birth and in early development of the brain it is often excitatory while neurons establish proper brain chemistry. During development there are specific times, called critical periods, where the brain is more capable of acquiring neural connections which usually leads to new behavioral and psychological skills. GABA’s change from excitatory to inhibitory, as well as other neurotransmitter changes during these critical developmental stages can impact the development the brain goes through. If the critical period is early, growth can be limited, slowed, or even stunted early on. Additionally, if it is later, the brain’s development is measured as complete incorrectly which may limit its ability to improve connectivity. Overall, the brain's circuitry and communication is often limited or poor within ASD, so using rodent models to study these limitations and where they come about increases researchers' understanding of the disorder and potential ways to prevent it5.


Songbird model

In 2012, a researcher from the University of Nebraska at Kearney published a study reviewing research that had been done using the songbird as a model for autism spectrum disorders, noting that the neurobiology of vocalization is similar between humans and songbirds, and that, in both species, social learning plays a central role in the development of the ability to vocalize.[27] Other research using this model has been done by Stephanie White at the University of California Los Angeles, who studied mutations in the FOXP2 gene and its potential role in learned vocalization in both songbirds (specifically the zebra finch) and humans.[28][29]

Controversy

In 2013, a study was published by Swiss researchers which concluded that 91% (31 out of the 34 studies reviewed) of valproic acid-autism studies using animal models suffered from statistical flaws—specifically, they had failed to correctly use the litter as a level of statistical analysis rather than just the individual (i.e., an individual mouse or rat).[30][31]

gollark: Not if I get the copper first! And actually remember to visit on the 5-minute drops!
gollark: fkkku or something in volcano.
gollark: At least to the degree of paying for itself.
gollark: I mean, it's kind of a business anyway.
gollark: Link please?

References
  1. Gogolia, Nadine (2009). "Common circuit defect of excitatory-inhibitory balance in mouse models of autism". Journal of Neurodevelopmental Disorders. 1 (2): 172–181. doi:10.1007/s11689-009-9023-x. PMC 2906812. PMID 20664807.
  2. Isshiki, Massaki. "Enhanced synapse remodeling as a common phenotype in mouse models of autism". Nature Communications. Retrieved 17 June 2020.
  3. Menon, V (2011). "Large-scale brain networks and psychopathology: A unifying triple network model". Trends in Cognitive Sciences. 15 (10): 483–506. doi:10.1016/j.tics.2011.08.003. PMID 21908230.
  4. Moy, S (2008). "Advances in behavioral genetics: mouse models of autism". Molecular Psychiatry. 13 (1): 4–26. doi:10.1038/sj.mp.4002082. PMID 17848915.
  5. Bourgeron, T.; Jamain, S. P.; Granon, S. (2006). "Animal Models of Autism". Transgenic and Knockout Models of Neuropsychiatric Disorders. Contemporary Clinical Neuroscience. p. 151. doi:10.1007/978-1-59745-058-4_8. ISBN 978-1-58829-507-1.
  6. Dicicco-Bloom, E.; Lord, C.; Zwaigenbaum, L.; Courchesne, E.; Dager, S. R.; Schmitz, C.; Schultz, R. T.; Crawley, J.; Young, L. J. (2006). "The Developmental Neurobiology of Autism Spectrum Disorder". Journal of Neuroscience. 26 (26): 6897–6906. doi:10.1523/JNEUROSCI.1712-06.2006. PMC 6673916. PMID 16807320.
  7. Callaway, E. (2011). "Rat models on the rise in autism research". Nature. doi:10.1038/nature.2011.9415.
  8. Oddi, D.; Crusio, W. E.; d'Amato, F. R.; Pietropaolo, S. (2013). "Monogenic mouse models of social dysfunction: Implications for autism". Behavioural Brain Research. 251: 75–84. doi:10.1016/j.bbr.2013.01.002. PMID 23327738.
  9. Vaccine Links to Autism?
  10. Hornig, M.; Chian, D.; Lipkin, W. I. (2004). "Neurotoxic effects of postnatal thimerosal are mouse strain dependent". Molecular Psychiatry. 9 (9): 833–845. doi:10.1038/sj.mp.4001529. PMID 15184908.
  11. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. ISBN 978-0-309-09237-1.CS1 maint: uses authors parameter (link)
  12. Doja A, Roberts W (2006). "Immunizations and autism: a review of the literature". Can J Neurol Sci. 33 (4): 341–6. doi:10.1017/s031716710000528x. PMID 17168158.
  13. World Health Organization (2006). "Thiomersal and vaccines: questions and answers". Retrieved 2009-05-19.
  14. "Thimerosal in vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 2008-06-03. Retrieved 2008-07-25.
  15. Centers for Disease Control (2008-02-08). "Mercury and vaccines (thimerosal)". Retrieved 2011-08-01.
  16. Crawley, J. N. (2012). "Translational animal models of autism and neurodevelopmental disorders". Dialogues in Clinical Neuroscience. 14 (3): 293–305. PMC 3513683. PMID 23226954.
  17. Klauck, S. M.; Poustka, A. (2006). "Animal models of autism". Drug Discovery Today: Disease Models. 3 (4): 313–318. doi:10.1016/j.ddmod.2006.11.005.
  18. Lewis, M.; Tanimura, Y.; Lee, L.; Bodfish, J. (2007). "Animal models of restricted repetitive behavior in autism". Behavioural Brain Research. 176 (1): 66–74. doi:10.1016/j.bbr.2006.08.023. PMC 3709864. PMID 16997392.
  19. Animal Models of Autism: Pathogenesis and Treatment
  20. Libbey, J.; Sweeten, T.; McMahon, W.; Fujinami, R. (2005). "Autistic disorder and viral infections". Journal of NeuroVirology. 11 (1): 1–10. doi:10.1080/13550280590900553. PMID 15804954.
  21. Pletnikov, M. V.; Moran, T. H.; Carbone, K. M. (2002). "Borna disease virus infection of the neonatal rat: Developmental brain injury model of autism spectrum disorders". Frontiers in Bioscience. 7 (1–3): d593–d607. doi:10.2741/pletnik. PMID 11861216.
  22. Roullet, F. I.; Lai, J. K. Y.; Foster, J. A. (2013). "In utero exposure to valproic acid and autism — A current review of clinical and animal studies". Neurotoxicology and Teratology. 36: 47–56. doi:10.1016/j.ntt.2013.01.004. PMID 23395807.
  23. Parker-Athill, E. C.; Tan, J. (2010). "Maternal Immune Activation and Autism Spectrum Disorder: Interleukin-6 Signaling as a Key Mechanistic Pathway". Neurosignals. 18 (2): 113–128. doi:10.1159/000319828. PMC 3068755. PMID 20924155.
  24. Wöhr, M.; Scattoni, M. L. (2013). "Behavioural methods used in rodent models of autism spectrum disorders: Current standards and new developments". Behavioural Brain Research. 251: 5–17. doi:10.1016/j.bbr.2013.05.047. PMID 23769995.
  25. Lim, M. M.; Bielsky, I. F.; Young, L. J. (2005). "Neuropeptides and the social brain: Potential rodent models of autism". International Journal of Developmental Neuroscience. 23 (2–3): 235–243. CiteSeerX 10.1.1.326.275. doi:10.1016/j.ijdevneu.2004.05.006. PMID 15749248.
  26. Chadman, K. K.; Guariglia, S. R.; Yoo, J. H. (2012). "New directions in the treatment of autism spectrum disorders from animal model research". Expert Opinion on Drug Discovery. 7 (5): 407–416. doi:10.1517/17460441.2012.678828. PMID 22494457.
  27. Panaitof, S. C. (2012). "A songbird animal model for dissecting the genetic bases of autism spectrum disorder". Disease Markers. 33 (5): 241–249. doi:10.1155/2012/727058. PMC 3810686. PMID 22960335.
  28. "Finding an Animal Model for Language Development". Archived from the original on 2016-12-19. Retrieved 2013-12-10.
  29. Condro, M. C.; White, S. A. (2014). "Distribution of language-related Cntnap2 protein in neural circuits critical for vocal learning". Journal of Comparative Neurology. 522 (1): 169–185. doi:10.1002/cne.23394. PMC 3883908. PMID 23818387.
  30. Lazic, S. E.; Essioux, L. (2013). "Improving basic and translational science by accounting for litter-to-litter variation in animal models". BMC Neuroscience. 14: 37. doi:10.1186/1471-2202-14-37. PMC 3661356. PMID 23522086.
  31. Varughese, Ansa (2 April 2013). "New Study Says 91% Of Autism Studies Using Certain Animal Models Are Statistically Flawed". Medical Daily. Retrieved 10 December 2013.

[1]

  1. Gadded, B. "Neuropathology and Animal Models of Autism: Genetic and Environmental Factors". Hindawi. Retrieved 3/1/20. Check date values in: |accessdate= (help)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.